Dupilumab besitzt einen Zusatznutzen für die Behandlung der chronischen Rhinosinusitis mit Nasenpolypen

BACKGROUND: For patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP) which cannot be controlled by continuous therapy with intranasal corticosteroids (INCS) and systemic corticosteroids and/or surgical treatment, there were no approved curative options for a long time. For CRSwNP t...

Descripción completa

Detalles Bibliográficos
Autores principales: Klimek, L., Chaker, A., Deitmer, T., Plontke, S. K., Wollenberg, B., Bousquet, J., Bachert, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2021
Materias:
Übersichten
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971351/
https://www.ncbi.nlm.nih.gov/pubmed/33738558
http://dx.doi.org/10.1007/s00106-021-01018-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971351/
https://www.ncbi.nlm.nih.gov/pubmed/33738558
http://dx.doi.org/10.1007/s00106-021-01018-z

Ejemplares similares